Therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas. Oren Sagher, M.D., professor of neurosurgery at U-M and author of this study, discusses the proceeding phases in the trials and how high-grade gliomas work overall.
![Doctor Disinfects Skin Of Patient Before Vaccination](https://alumni.umich.edu/wp-content/uploads/iStock-872604412.jpg)